Executive Director at Veterans For Medical Cannabis Access, Head of the Working Group on the Preparation of the WHO report, USA.

Head of Research department at FAAAT (For Alternative Approaches to Addiction, Think & do tank), France.

Doctor in political science, an independent researcher associated to the Department of Sociology at Geneva University. Starting from 2014, he focused on cannabis policy reforms, research and analysis of cannabis policies, regulatory practices, discourse on reforms and networks of stakeholders in Switzerland and world practice. As well he collaborates with the Federal Commission for Addiction Issues (EKSF), the international NGO FAAAT and the Romand Group for the Study of Addictions (Groupement Romand d’Etudes des Addictions, GREA), which is organized by Swiss cannabis activists.

The former Head of the Czech Government Council For Drug Policy Coordination, the author of the Czech law on medical cannabis, currently running for the European Parliament. Former Deputy Director of the INCB (International Narcotics Control Board).

Doctor, specialist in general and forensic psychiatry, psychopharmacology and neuropsychiatry. Currently, he coordinates the activity of Israel National Forum/Association for Medical Cannabis Research & Treatment and serves as a professional advisor (and permanent participant and observer) to Israeli Parliament (Knesset) Committee for Drugs and Alcohol Control and to Parliamentary Public Lobby for Medicinal Cannabis. Member of the Board of Directors of the International Association of Cannabinoid Medicine (IACM).

Czech analytical chemist and a leading expert in cannabis research. In 1992, along with William Anthony Devane he identified and described for the first time the structure of anandamide, an endogenous cannabinoid neurotransmitter.

German activist, a member of the movement for the access of medical patients to the treatment by medical cannabis. One of the first patients in Germany who achieved the right to use medical cannabis as an anesthetic under the supervision of his doctor.

Emanuel Kotzian devoted himself to educational activities on the influence of cannabis and lobbied the renormalization of a plant. In 2000, he founded the largest German magazine "Hanf Journal", also he is a CEO of the company "Agentur Sowjet GmbH." With more than 1 million fans, followers and readers on multiple channels, Agentur Sowjet is one of the leading marketing companies on the European hemp market. Network of his companies and affiliates extends from the Canary Islands to Ukraine, and in addition to the German Hanf Journal, it includes publications in such languages as Polish (Spliff), Czech (Konoptikum), French (RBH23) and Ukrainian (Konopliana Pravda).

PhD, USA. He was invited by the United States Navy and the University of Washington (WSU) to take part in practical scientific work on Traumatic Brain Injury (TBI) and Post Traumatic Stress Disorder (PTSD) at the ROLE 3 NATO Forces, Kandahar, Afghanistan. For two years in Afghanistan, he assisted in the treatment of more than 1,700 traumatic injuries of varying severity, and co-authored the research on the impact of medical cannabis on emotional disorders, including PTSD.

Secretary of the Unión de Pacientes por la Regulación del Cannabis (Union of Patients for the Regulation of Cannabis) in Barcelona. Cannabis Therapies patient for 15 years. Carlos has suffered all kinds of injuries and conditions, from breaks in the tibia and fibula, clavicle and wrists, to herniated discs, prostatitis, tinnitus and colon cancer. Today at 60, he only "medicates" with Cannabis Therapies, based on high concentrations of CBD.